A Phase 2, Open-label Study of Zanubrutinib (BGB-3111) in Patients with Relapsed or Refractory Marginal Zone Lymphoma

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/CRGH/215 (ERM Project ID: 48385)
NMA SSA Reference Number: SSA/48385/MonH-2018-156789
Monash Health Ref: RES-18-0000-716X

StatusActive
Effective start/end date14/12/1813/12/23